ABSTRACT
The aims of this study were to evaluate the prevalence of upper body quadrant pain among Israeli professional urban bus drivers and to evaluate the association between individual, ergonomic, and psychosocial risk factors and occurrence of neck pain. Three hundred and eighty-four male urban bus drivers were consecutively enrolled in the study. Data pertaining to work-related ergonomic and psychosocial stress factors were collected. The 12-month prevalence of neck pain was 21.2%, followed by shoulder: 14.7%, upper back: 8.3%, elbow: 3.0%, and wrist: 3.0% pain. Prevalence of neck pain was associated with uncomfortable seats (odds ratio; OR [95% confidence interval; CI]: 2.2 [1.2-4.3], back support (2.3 [1.2-4.2]), and steering wheel (2.2 [1.1-4.5]). Drivers with neck pain reported significantly higher prevalence of pain in the upper back (OR [95% CI]: 5.9 [2.7-12.9]), shoulders (8.1 [4.3-15.3]), and wrists (7.0 [2.0-21.8]) compared to drivers without neck pain. Work-related organizational stress factors were not associated with neck pain prevalence.
Subject(s)
Automobile Driving , Motor Vehicles , Neck Pain/epidemiology , Occupational Diseases/epidemiology , Automobile Driving/statistics & numerical data , Chi-Square Distribution , Confidence Intervals , Cross-Sectional Studies , Ergonomics/statistics & numerical data , Humans , Israel/epidemiology , Male , Middle Aged , Motor Vehicles/statistics & numerical data , Neck Pain/etiology , Occupational Diseases/etiology , Odds Ratio , Prevalence , Psychology , Risk Factors , Shoulder Pain/epidemiology , Shoulder Pain/etiologyABSTRACT
Un estudio simple, abierto, multicéntrico, se enrolaron 93 pacientes (43 varones y 48 mujeres) mayores de 18 años con tinea unguis de pies, quienes recibieron terbinafina (Lamisil), 250 mg diarios por 90 días. De ellos se aislaron 71 cepas de Trichophyton rubrum, 21 de Tr. mentagrophytes y 1 de Epidermophyton floccosum. Al término de la medicación (3 meses), se presentaron 67 pacientes, 65 de los cuales (96,5 por ciento) resultaron negativos al examen micológico. A los 3 meses de seguimiento, un paciente más resultó negativo. A los 6 meses de seguimiento, se registró recaída. Cuatro pacientes mostraron leves efectos secundarios adversos; dos de ellos se retiraron del estudio. En conclusión, pensamos que, bajo las condiciones del presente ensayo, la terbinafina (Lamisil) ha mostrado rápida e intensa actividad y alta tolerabilidad
